首页> 外文期刊>International journal of clinical pharmacology and therapeutics >Prevalence and type of antidepressant therapy used by German general practitioners to treat female patients with osteoporosis
【24h】

Prevalence and type of antidepressant therapy used by German general practitioners to treat female patients with osteoporosis

机译:德国全科医生用于治疗骨质疏松症女性患者的抗抑郁治疗的患病率和类型

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To estimate the prevalence and type of antidepressant medication prescribed by German primary care physicians for patients with depression and osteoporosis. Methods: This study was a retrospective database analysis conducted in Germany utilizing the Disease Analyzer (R) Database (IMS Health, Germany). The study population included 3,488 female osteoporosis patients aged between 40 and 90 years recruited from 1,179 general practitioner practices and who were initially diagnosed with depression during the index period (January 2004 to December 2013). Follow-up lasted up to 12 months and was completed in August 2015. Also included in this study were 3,488 nonosteoporosis controls who were matched (1 : 1) to osteoporosis cases on the basis of age, health insurance coverage, severity of depression, and physician carrying out the diagnosis. Results: After 12 months of followup, 30.1% of osteoporosis and 29.9% of nonosteoporosis patients with mild depression (p = 0.783), 52.4% of osteoporosis and 48.0% of non-osteoporosis patients with moderate depression (p = 0.003), and 39.4% of osteoporosis and 35.1% of nonosteoporosis patients with severe depression (p = 0.147) were being treated with antidepressants. Osteoporosis patients with moderate depression had a higher chance of being prescribed antidepressant therapy at the initial diagnosis (hazard ratio (HR): 1.12, p = 0.014). No differences were found between osteoporosis and nonosteoporosis patients regarding the proportion of patients receiving selective serotonin reuptake inhibitors (SSRI)/serotonin-noradrenaline reuptake inhibitors (SNRI), tricyclic antidepressant (TCA), or other antidepressants. Osteoporosis patients were more often referred to hospitals or psychiatrists for consultation. Conclusion: Osteoporosis patients are more often treated initially with antidepressants than non-osteoporosis patients, especially within the groups of patients with moderate or severe depression. TCA was the most frequently used antidepressant therapy class on initial diagnosis in both patient groups. Osteo-porosis patients receive referrals to hospitals or psychiatrists more often than patients without osteoporosis.
机译:目的:评估德国初级保健医生为抑郁症和骨质疏松症患者开具的抗抑郁药的患病率和类型。方法:本研究是在德国使用疾病分析器(R)数据库(IMS Health,德国)进行的回顾性数据库分析。研究人群包括从1,179名全科医生中招募的3,488名年龄在40至90岁之间的女性骨质疏松患者,这些患者最初在该指数期间(2004年1月至2013年12月)被诊断出患有抑郁症。随访持续了12个月,并于2015年8月完成。该研究还包括3488名非骨质疏松症对照者,他们根据年龄,健康保险范围,抑郁严重程度和年龄与骨质疏松症病例匹配(1:1)。医生进行诊断。结果:随访12个月后,轻度抑郁症的骨质疏松症患者占30.1%,非骨质疏松症患者占29.9%(p = 0.783),中度抑郁症的骨质疏松患者占52.4%,非骨质疏松症患者占48.0%(p = 0.003),而39.4%接受抗抑郁药治疗的骨质疏松症患者百分比为31.0%,非骨质疏松症患者率为35.1%(p = 0.147)。在初诊时,患有中度抑郁症的骨质疏松患者更有可能接受抗抑郁药的处方治疗(危险比(HR):1.12,p = 0.014)。在接受选择性5-羟色胺再摄取抑制剂(SSRI)/ 5-羟色胺-去甲肾上腺素再摄取抑制剂(SNRI),三环抗抑郁药(TCA)或其他抗抑郁药的患者比例方面,骨质疏松症和非骨质疏松症患者之间没有发现差异。骨质疏松症患者更常被转诊到医院或精神科医生进行咨询。结论:与非骨质疏松症患者相比,骨质疏松症患者最初更常接受抗抑郁药治疗,尤其是在中度或重度抑郁症患者组中。在两个患者组中,TCA是最初诊断时最常用的抗抑郁药。骨质疏松症患者比没有骨质疏松症的患者更经常被转诊到医院或精神病医生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号